Cargando…
Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia: A Multi-Stakeholder Perspective
The US Food and Drug Agency (FDA) requires clinical trials targeting cognitive impairment associated with schizophrenia (CIAS) to demonstrate the functional relevance of cognitive improvements by employing a functional co-primary measure. Although quantitative evidence supports the suitability of th...
Autores principales: | Horan, William P, Depp, Colin A, Hurst, Samantha, Linthicum, Jared, Vargas, Gabriela, Klein, Hans, Keefe, Richard S E, Harvey, Philip D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664622/ https://www.ncbi.nlm.nih.gov/pubmed/38026054 http://dx.doi.org/10.1093/schizbullopen/sgad012 |
Ejemplares similares
-
Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson’s Disease
por: Turner, Travis H., et al.
Publicado: (2021) -
Virtual reality applications in Schizophrenia
por: Uvais, N. A.
Publicado: (2015) -
Virtual reality-based interventions for schizophrenia
por: Nordentoft, M.
Publicado: (2023) -
Dyadic Interactions of Treatment-Resistant Schizophrenia Patients Having Followed Virtual Reality Therapy: A Content Analysis
por: Hudon, Alexandre, et al.
Publicado: (2023) -
T59. VIRTUAL REALTY ASSESSMENT OF FUNCTIONAL CAPACITY IN EARLY SCHIZOPHRENIA: ASSOCIATIONS WITH NEUROCOGNITION, FUNCTIONAL CAPACITY PERFORMANCE, AND DAILY FUNCTIONING
por: Ventura, Joseph, et al.
Publicado: (2018)